Excretion of herpes simplex virus type 2 glycoprotein D into the culture medium

Journal of General Virology

Volumn 83, Issue 11, 2002, Pages 2791-2795

  Murata, Takayuki ^a   Goshima, Fumi ^a   Takakuwa, Hiroki ^a   Nishiyama, Yukihiro ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; GLYCOPROTEIN D; LECTIN; TUNICAMYCIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; LECTIN BINDING; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN SECRETION;

DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 2;

EID: 0036842072     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-11-2791     Document Type: Article

References (31)

1. Baenziger, J. U. & Fiete, D. (1979). Structural determinants of concanavalin A specificity for oligosaccharides. Journal of Biological Chemistry 254, 2400-2407.
2. Barrett, A. J. (1980). The many forms and functions of cellular proteinases. Federation Proceedings 39, 9-14.
3. Bolt, G., Pedersen, L. O. & Birkeslund, H. H. (2000). Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furin. Virus Research 68, 25-33.
4. Campadelli-Fiume, G., Arsenakis, M., Farabegoli, F. & Roizman, B. (1988). Entry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in degradation of the virus. Journal of Virology 62, 159-167.
5. Campadelli-Fiume, G., Cocchi, F., Menotti, L. & Lopez, M. (2000). The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Reviews in Medical Virology 10, 305-319.
6. Claesson-Welsh, L. & Spear, P. G. (1986). Oligomerization of herpes simplex virus glycoprotein B. Journal of Virology 60, 803-806.
7. Fullar, A. O. & Spear, P. G. (1987). Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface. Proceedings of the National Academy of Sciences, USA 84, 5454-5458.
8. Hampl, H., Ben-Porat, T., Ehrlicher, L., Habermehl, K. O. & Kaplan, A. S. (1984). Characterization of the envelope proteins of pseudorabies virus. Journal of Virology 52, 583-590.
9. Highlander, S. L., Sutherland, S. L., Gage, P. J., Johnson, D. C., Levine, M. & Glorioso, J. C. (1987). Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. Journal of Virology 61, 3356-3364.
10. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H. & Johnson, D. (1995). Herpes simplex virus turns off the TAP to evade host immunity. Nature 375, 411-415.
11. Huemer, H. P., Wang, Y., Garred, P., Koistinen, V. & Oppermann, S. (1993). Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein. Immunology 79, 639-647.
12. Inoue, Y., Ohashi, Y., Shimomura, Y., Manabe, R., Yamada, M., Ueda, S. & Kato, S. (1990). Herpes simplex virus glycoprotein D. Protective immunity against murine herpetic keratitis. Investigative Ophthalmology & Visual Science 31, 411-418.
13. Jankovics, I. (1996). The influenza viruses: past, present and future. Lege Artis Medicinae 6, 62-68.
14. Johnson, D. C. & Spear, P. G. (1982). Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells. Journal of Virology 43, 1102-1112.
15. Johnson, D. C., Frame, M. C., Ligas, M. W., Cross, A. M. & Stow, N. D. (1988). Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. Journal of Virology 62, 1347-1354.
16. Johnson, D. C., Burke, R. L. & Gregory, T. (1990). Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells. Journal of Virology 64, 2569-2576.
17. Lenz, O., ter Meulen, J., Klenk, H. D., Seidah, N. G. & Garten, W. (2001). The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proceedings of the National Academy of Sciences, USA 98, 12701-12705.
18. Ligas, M. W. & Johnson, D. C. (1988). A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells. Journal of Virology 62, 1486-1494.
19. Liu, F. & Roizman, B. (1992). Differentiation of multiple domains in the herpes simplex virus 1 protease encoded by the UL26 gene. Proceedings of the National Academy of Sciences, USA 89, 2076-2080.
20. Mahoney, W. C. & Duksin, D. (1979). Biological activities of the two major components of tunicamycin. Journal of Biological Chemistry 254, 6572-6576.
21. Montalvo, E. A. & Grose, C. (1987). Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140). Journal of Virology 61, 2877-2884.
22. Murata, T., Goshima, F., Daikoku, T., Takakuwa, H. & Nishiyama, Y. (2000). Expression of herpes simplex virus type 2 US3 affects the Cdc42/Rac pathway and attenuates c-Jun N-terminal kinase activation. Genes to Cells 5, 1017-1027.
23. Noble, A. G., Lee, G. T., Sprague, R., Parish, M. L. & Spear, P. G. (1983). Anti-gD monoclonal antibodies inhibit cell fusion induced by herpes simplex virus type 1. Virology 129, 218-224.
24. Randall, R. E., Killington, R. A. & Watson, D. H. (1980). Glycoproteins with type common and type specific antigenic sites excreted from cells infected with herpes simplex virus type 1 and 2. Journal of General Virology 48, 297-310.
25. Rooney, J. F., Wohlenberg, C., Cremer, K. J. & Notkins, A. L. (1989). Immunized mice challenged with herpes simplex virus by the intranasal route show protection against latent infection. Journal of Infectious Diseases 159, 974-976.
26. Serafini-Cessi, F. & Campadelli-Fiume, G. (1981). Studies on benzhydrazone, a specific inhibitor of herpesvirus glycoprotein synthesis. Size distribution of glycopeptides and endo-b-N-acetylglucosamidase H treatment. Archives of Virology 70, 331-343.
27. Spaete, R. R., Thayer, R. M., Probert, W. S., Masiarz, F. R., Chamberlain, S. H., Rasmussen, L., Merigan, T. C. & Pachl, C. (1988). Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167, 207-225.
28. Strous, G. J., van Kerkhof, P., van Meer, G., Rijnboutt, S. & Stoorvogel, W. (1993). Differential effects of brefeldin A on transport of secretory and lysosomal proteins. Journal of Biological Chemistry 268, 2341-2347.
29. Vey, M., Schafer, W., Reis, B., Ohuchi, R., Britt, W., Garten, W., Klenk, H. D. & Radsak, K. (1995). Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin. Virology 206, 746-749.
30. Zarling, J. M., Moran, P. A., Burke, R. L., Pachl, C., Berman, P. W. & Lasky, L. A. (1986). Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. Journal of Immunology 136, 4669-4673.
31. Zhou, G., Galvan, V., Campadelli-Fiume, G. & Roizman, B. (2000). Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins. Journal of Virology 74, 11782-11791.